Skip to main content

Table 4 Safety profile

From: Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study

Toxicity

Number of patients

Hypertension (grade II)

1(5.2%)

Blood diarrhoea (grade III)

1(5.2%)

Slight epistaxis (grade I)

3(15.8%)